Bantek Inc (BANT)

[Drugdoctor]

It actually looks a bit hopeless for common-shareholders at this point...

They did have slightly higher profit margins on less revenues generated, so they ended up doing about the same gross profit as last year. However the convertible loans are tremendous, and the NET LOSSES were still horrible, if not as horrible as last year...

The problem is... last year the stock price was much much higher, so there was a glimmer of hope that loans could be paid off in stock, and the margins could be raised, and the company could become profitable on the millions and millions of dollars of revenues generated...

Sigh.... now the stock price is so low, that using the stock to pay off loans is not going to significantly lower the debts, and they are still burning a huge amount of cash each quarter, so, at some point in 2019, I assume they will reverse split the shares, and use those new shares to try and pay down the debts...

Until then, expect huge increases in the outstanding share counts, and no appreciation in the share price... GLTA